The news: Healthcare and pharma stakeholders are concerned that President Trump’s tariffs on products imported from Canada, Mexico, and China will increase costs for patients and put greater operational pressure on manufacturers.
Catch up quick: The US agreed to postpone Canada and Mexico tariffs for a month, only a few days after Trump said he would impose a 25% levy on goods shipped from both countries. Meanwhile, a 10% charge on imports from China went into effect on Tuesday.
Why it matters: The US depends greatly on China, Mexico, and Canada for pharmaceuticals and the chemicals needed to make them. It also leans on outside nations for medical devices, equipment, and technology.